Approval · Notice of Compliance 14288 · 2013
PERJETA: Notice of Compliance 14288
Issued April 12, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14288
- Date
- April 12, 2013
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PERJETA | 02405016 | Marketed |
| PERJETA (PERJETA-HERCEPTIN COMBO PACK) | 02405024 | Marketed |
Medicinal ingredients
- PERTUZUMAB 420 MG per VIAL
- TRASTUZUMAB 440 MG per VIAL